This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Synapse B.v.. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Hilde Kelchtermans: Innovator in Thrombin Measurement Technology
Introduction
Hilde Kelchtermans is a notable inventor based in Meeuwen-Gruitrode, Belgium. She has made significant contributions to the field of medical technology, particularly in the measurement of thrombin generation and clot strength. Her innovative approach has the potential to enhance diagnostic capabilities in various medical settings.
Latest Patents
Hilde holds a patent for a method titled "Simultaneous measurement of thrombin generation and clot strength in plasma and whole blood." This invention provides a method for the simultaneous measurement of proteolytic enzyme generation and clot strength in plasma or whole blood, or any appropriate biological sample derived from blood. The measurement method utilizes a detectable substrate that includes a moiety that can be released upon reaction with the targeted proteolytic enzyme, along with elements for measuring an increase in viscosity of clot strength. This patent showcases her expertise and commitment to advancing medical diagnostics.
Career Highlights
Hilde is associated with Synapse B.V., where she applies her knowledge and skills to further develop innovative solutions in the medical field. Her work at Synapse B.V. reflects her dedication to improving healthcare through technology.
Collaborations
Hilde collaborates with esteemed colleagues such as Bas H De Laat and Hendrik Coenraad Hemker. These partnerships enhance her research and development efforts, contributing to the advancement of medical technologies.
Conclusion
Hilde Kelchtermans is a pioneering inventor whose work in thrombin measurement technology is making a significant impact in the medical field. Her innovative methods and collaborations are paving the way for improved diagnostic tools and better patient outcomes.